MYELOID DERIVED SUPPRESSIVE CELLS ATTENUATE THE ANTI-TUMOR EFFICACY OF ANDROGEN DEPRIVATION THERAPY AND TARGETED RADIONUCLIDE THERAPY IN A MURINE PROSTATE CANCER MODEL

被引：0
|
作者：
Muralidhar, Anusha [1 ]
Ferreira, Carolina de Aguiar [1 ]
Hernandez, Reinier [1 ]
Weichert, Jamey [1 ]
McNeel, Douglas [1 ]
机构：
[1] Univ Wisconsin Madison, Madison, WI USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.0893
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
893
引用
收藏
页码：A930 / A930
页数：1
相关论文
共 50 条
  • [31] UTILIZING METFORMIN TO ENHANCE THE EFFICACY OF ANDROGEN DEPRIVATION THERAPY IN THE TREATMENT OF PROSTATE CANCER.
    Colquhoun, Alexandra
    Venier, Natalie
    Fleshner, Neil
    Pollak, Michael
    Klotz, Laurence
    Venkateswaran, Vasundara
    JOURNAL OF UROLOGY, 2010, 183 (04): : E41 - E41
  • [32] Utilizing metformin to enhance the efficacy of androgen-deprivation therapy in the treatment of prostate cancer
    Klotz, L.
    Venier, N.
    Vandersluis, A.
    Besla, R.
    Fleshner, N.
    Pollak, M. N.
    Venkateswaran, V.
    Colquhoun, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [33] Pharmacological inhibition of the Notch pathway enhances the efficacy of androgen deprivation therapy for prostate cancer
    Cui, Jian
    Wang, Yanqing
    Dong, Baijun
    Qin, Lixia
    Wang, Chao
    Zhou, Peijie
    Wang, Xue
    Xu, Huiming
    Xue, Wei
    Fang, Yu-Xiang
    Gao, Wei-Qiang
    INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (03) : 645 - 656
  • [34] Efficacy of Intermittent Androgen Deprivation Therapy vs Conventional Continuous Androgen Deprivation Therapy for Advanced Prostate Cancer: A Meta-analysis EDITORIAL COMMENT
    Filson, Christopher P.
    Hollingsworth, John M.
    UROLOGY, 2013, 82 (02) : 333 - 334
  • [35] Efficacy and Adverse Events of Intermittent Androgen Deprivation Therapy versus Continuos Androgen Deprivation Therapy on Localized and Metastatic Prostate Cancer: A Meta-Analysis
    Arif, M. Gozali
    Hamid, Rizal A. H.
    ADVANCED SCIENCE LETTERS, 2018, 24 (08) : 6130 - 6135
  • [36] Development of a prostate cancer PDX model radioresistant to PSMA targeted radionuclide therapy
    Thaysen, Maria
    Christensen, Esben
    Nielsen, Rikke N.
    Wick, Michael
    Wessel, Mette M.
    Kristensen, Lotte K.
    Gnosa, Sebastian
    Nielsen, Carsten H.
    CANCER RESEARCH, 2023, 83 (07)
  • [37] Combined vaccine plus axitinib therapy yields superior anti-tumor efficacy in a murine melanoma model
    Lowe, D. B.
    Bose, A.
    Storkus, W. J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S104 - S104
  • [38] The association between monocytic myeloid-derived suppressor cells levels and the anti-tumor efficacy of anti-PD-1 therapy in NSCLC patients
    Feng, Jiuxing
    Chen, Shujing
    Li, Shuangqi
    Wu, Baitong
    Lu, Jiacheng
    Tan, Li
    Li, Jiamin
    Song, Yuanlin
    Shi, Guoming
    Shi, Yujiang Geno
    Jiang, Jinjun
    TRANSLATIONAL ONCOLOGY, 2020, 13 (12):
  • [39] Dopamine receptor antagonists sensitize prostate cancer cells to androgen targeted therapy
    Zhang, Le
    Billet, Sandrine
    Gonzales, Gabrielle
    Rohena-Rivera, Krizia
    Muranaka, Hayato
    Lee, Yeonjoo
    You, Sungyong
    Posadas, Edwin M.
    Bhowmick, Neil A.
    CANCER RESEARCH, 2023, 83 (11)
  • [40] Radionuclide therapy of melanoma: anti-tumor efficacy of a new vector labeled with iodine-131
    Bonnet-Duquennoy, Mathilde
    Janine, Papon
    Florence, Mishellany
    Jean-Luc, Guerquin-Kern
    Jean, Maublant
    Elisabeth, Miot-Noirault
    Anne, Cayre
    Jean-Claude, Madelmont
    Jean-Michel, Chezal
    Nicole, Moins
    BULLETIN DU CANCER, 2009, 96 : S8 - S8
12345